- cafead Jun 11, 2024 at 11:42: AM
via Amid a recent biopharma M&A resurgence, one major player plans to stay out of the waters after making multiple recent splashes.
Though not for lack of business development capacity, Pfizer is currently taking a large dealmaking “breathing period,” CEO Albert Bourla told investors this week at Goldman Sachs’ 2024 annual Global Healthcare Conference in Miami.
article source
Though not for lack of business development capacity, Pfizer is currently taking a large dealmaking “breathing period,” CEO Albert Bourla told investors this week at Goldman Sachs’ 2024 annual Global Healthcare Conference in Miami.
article source